.png)
Contraceptive Market by Drug Typeand Device- Global Industry Analysis & Forecast to 2027
Published On : December 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC1214019
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Contraceptive Market By Drug Type(Oral Contraceptive Pills, Injectable, Topical), By Device (Male, Female Condoms, Copper, Hormonal IUD, Vaginal Rings, Subdermal Implants)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Contraceptive Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Contraceptives helps to prevent a woman from becoming pregnant. In any social context effective contraception allows a couple to enjoy a physical relationship without fear of an unwanted pregnancy and ensures enough freedom to have children when desired
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Contraceptive Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Teva Pharmaceutical Industries
- The Female Health Company
- Reckitt Benckiser Plc
- Pfizer Inc.
- Church & Dwight
- Mayer Laboratories
- Cooper Surgical
- Actavis plc,
- Merck & Co.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Contraceptive Market, ByDrug Type, Estimates and Forecast, 2017-2027 ($Million)
o Oral Contraceptive Pills
o Injectable
o Topical
· Contraceptive Market, ByDevice, Estimates and Forecast, 2017-2027 ($Million)
o Male
o Female Condoms
o Copper
o Hormonal IUD
o Vaginal Rings
o Subdermal Implants
· Contraceptive Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Teva Pharmaceutical Industries
o The Female Health Company
o Reckitt Benckiser Plc
o Pfizer Inc.
o Church & Dwight
o Mayer Laboratories
o Cooper Surgical
o Actavis plc,
o Merck & Co.
· Contraceptive Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Contraceptive Market, By Country
o U.S. Contraceptive Market
o Canada Contraceptive Market
o Mexico Contraceptive Market
o Europe
§ Europe Contraceptive Market, By Country
o UK Contraceptive Market
o Germany Contraceptive Market
o France Contraceptive Market
o Russia Contraceptive Market
o Italy Contraceptive Market
o Rest of Europe Contraceptive Market
o Asia-Pacific
§ Asia-Pacific Contraceptive Market, By Country
o China Contraceptive Market
o Japan Contraceptive Market
o South Korea Contraceptive Market
o India Contraceptive Market
o Southeast Asia Contraceptive Market
o Rest of Asia-Pacific Contraceptive Market
o South America
§ South America Contraceptive Market
o Brazil Contraceptive Market
o Argentina Contraceptive Market
o Columbia Contraceptive Market
o Rest of South America Contraceptive Market
o Middle East and Africa
§ Middle East and Africa Contraceptive Market
o Saudi Arabia Contraceptive Market
o UAE Contraceptive Market
o Egypt Contraceptive Market
o Nigeria Contraceptive Market
o South Africa Contraceptive Market
o TurkeyContraceptive Market
o Rest of MEA Contraceptive Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Contraceptive Market, By Drug Type
5.1. Introduction
5.2. Global Contraceptive Revenue and Market Share by Drug Type (2017-2021)
5.2.1. Global Contraceptive Revenue and Revenue Share by Drug Type (2017-2021)
5.3. Oral Contraceptive Pills
5.3.1. Global Oral Contraceptive Pills Revenue and Growth Rate (2017-2021)
5.4. Injectable
5.4.1. Global Injectable Revenue and Growth Rate (2017-2021)
5.5. Topical
5.5.1. Global Topical Revenue and Growth Rate (2017-2021)
6. Contraceptive Market, By Device
6.1. Introduction
6.2. Global Contraceptive Revenue and Market Share by Device (2017-2021)
6.2.1. Global Contraceptive Revenue and Revenue Share by Device (2017-2021)
6.3. Male
6.3.1. Global Male Revenue and Growth Rate (2017-2021)
6.4. Female Condoms
6.4.1. Global Female Condoms Revenue and Growth Rate (2017-2021)
6.5. Copper
6.5.1. Global Copper Revenue and Growth Rate (2017-2021)
6.6. Hormonal IUD
6.6.1. Global Hormonal IUD Revenue and Growth Rate (2017-2021)
6.7. Vaginal Rings
6.7.1. Global Vaginal Rings Revenue and Growth Rate (2017-2021)
6.8. Subdermal Implants
6.8.1. Global Subdermal Implants Revenue and Growth Rate (2017-2021)
7. Contraceptive Market, By Region
7.1. Introduction
7.2. Global Contraceptive Revenue and Market Share by Regions
7.2.1. Global Contraceptive Revenue by Regions (2017-2021)
7.3. North America Contraceptive by Countries
7.3.1. North America Contraceptive Revenue and Growth Rate (2017-2021)
7.3.2. North America Contraceptive Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Contraceptive by Countries
7.4.1. Europe Contraceptive Revenue and Growth Rate (2017-2021)
7.4.2. Europe Contraceptive Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Contraceptive by Countries
7.5.1. Asia-Pacific Contraceptive Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Contraceptive Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Contraceptive by Countries
7.6.1. South America Contraceptive Revenue and Growth Rate (2017-2021)
7.6.2. South America Contraceptive Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Contraceptive by Countries
7.7.1. Middle East and Africa Contraceptive Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Contraceptive Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Contraceptive Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Teva Pharmaceutical Industries
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. The Female Health Company
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Reckitt Benckiser Plc
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Pfizer Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Church & Dwight
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Mayer Laboratories
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Cooper Surgical
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Actavis plc,
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Merck & Co.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Contraceptive Market Forecast (2022-2027)
9.1. Global Contraceptive Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Contraceptive Market Forecast by Regions (2022-2027)
9.2.1. North America Contraceptive Market Forecast (2022-2027)
9.2.1.1. United States Contraceptive Market Forecast (2022-2027)
9.2.1.2. Canada Contraceptive Market Forecast (2022-2027)
9.2.1.3. Mexico Contraceptive Market Forecast (2022-2027)
9.2.2. Europe Contraceptive Market Forecast (2022-2027)
9.2.2.1. Germany Contraceptive Market Forecast (2022-2027)
9.2.2.2. France Contraceptive Market Forecast (2022-2027)
9.2.2.3. UK Contraceptive Market Forecast (2022-2027)
9.2.2.4. Russia Contraceptive Market Forecast (2022-2027)
9.2.2.5. Italy Contraceptive Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Contraceptive Market Forecast (2022-2027)
9.2.3. Asia-Pacific Contraceptive Market Forecast (2022-2027)
9.2.3.1. China Contraceptive Market Forecast (2022-2027)
9.2.3.2. Japan Contraceptive Market Forecast (2022-2027)
9.2.3.3. Korea Contraceptive Market Forecast (2022-2027)
9.2.3.4. India Contraceptive Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Contraceptive Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Contraceptive Market Forecast (2022-2027)
9.2.4. South America Contraceptive Market Forecast (2022-2027)
9.2.4.1. Brazil Contraceptive Market Forecast (2022-2027)
9.2.4.2. Argentina Contraceptive Market Forecast (2022-2027)
9.2.4.3. Columbia Contraceptive Market Forecast (2022-2027)
9.2.4.4. Rest of South America Contraceptive Market Forecast (2022-2027)
9.2.5. Middle East and Africa Contraceptive Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Contraceptive Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Contraceptive Market Forecast (2022-2027)
9.2.5.3. Egypt Contraceptive Market Forecast (2022-2027)
9.2.5.4. Nigeria Contraceptive Market Forecast (2022-2027)
9.2.5.5. South Africa Contraceptive Market Forecast (2022-2027)
9.2.5.6. Turkey Contraceptive Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Contraceptive Market Forecast (2022-2027)
9.3. Contraceptive Market Forecast by Drug Type (2022-2027)
9.3.1. Contraceptive Forecast by Drug Type (2022-2027)
9.3.2. Contraceptive Market Share Forecast by Drug Type (2022-2027)
9.4. Contraceptive Market Forecast by Device (2022-2027)
9.4.1. Contraceptive Forecast by Device (2022-2027)
9.4.2. Contraceptive Market Share Forecast by Device (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Contraceptive Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Contraceptive Revenue and Revenue Share by Drug Type (2017-2019)
Figure Global Oral Contraceptive Pills Revenue and Growth Rate (2017-2019)
Figure Global Injectable Revenue and Growth Rate (2017-2019)
Figure Global Topical Revenue and Growth Rate (2017-2019)
Table Global Contraceptive Revenue and Revenue Share by Device (2017-2019)
Figure Global Male Revenue and Growth Rate (2017-2019)
Figure Global Female Condoms Revenue and Growth Rate (2017-2019)
Figure Global Copper Revenue and Growth Rate (2017-2019)
Figure Global Hormonal IUD Revenue and Growth Rate (2017-2019)
Figure Global Vaginal Rings Revenue and Growth Rate (2017-2019)
Figure Global Subdermal Implants Revenue and Growth Rate (2017-2019)
Table Global Contraceptive Revenue by Regions (2017-2019)
Figure North America Contraceptive Growth Rate (2017-2019)
Figure North America Contraceptive Revenue and Growth Rate (2017-2019)
Figure North America Contraceptive by Countries (2017-2019)
Figure North America Contraceptive Revenue (Million USD) by Countries (2017-2019)
Figure United States Contraceptive Growth Rate (2017-2019)
Figure United States Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Contraceptive Growth Rate (2017-2019)
Figure Canada Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Contraceptive Growth Rate (2017-2019)
Figure Mexico Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Contraceptive Growth Rate (2017-2019)
Figure Europe Contraceptive Revenue and Growth Rate (2017-2019)
Figure Europe Contraceptive by Countries (2017-2019)
Figure Europe Contraceptive Revenue (Million USD) by Countries (2017-2019)
Figure Germany Contraceptive Growth Rate (2017-2019)
Figure Germany Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Contraceptive Growth Rate (2017-2019)
Figure France Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Contraceptive Growth Rate (2017-2019)
Figure UK Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Contraceptive Growth Rate (2017-2019)
Figure Russia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Contraceptive Growth Rate (2017-2019)
Figure Italy Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Contraceptive Growth Rate (2017-2019)
Figure Rest of Europe Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Contraceptive Growth Rate (2017-2019)
Figure Asia-Pacific Contraceptive Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Contraceptive by Countries (2017-2019)
Figure Asia-Pacific Contraceptive Revenue (Million USD) by Countries (2017-2019)
Figure China Contraceptive Growth Rate (2017-2019)
Figure China Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Contraceptive Growth Rate (2017-2019)
Figure Japan Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Contraceptive Growth Rate (2017-2019)
Figure Korea Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Contraceptive Growth Rate (2017-2019)
Figure India Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Contraceptive Growth Rate (2017-2019)
Figure Southeast Asia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Contraceptive Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Contraceptive Growth Rate (2017-2019)
Figure South America Contraceptive Revenue and Growth Rate (2017-2019)
Figure South America Contraceptive by Countries (2017-2019)
Figure South America Contraceptive Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Contraceptive Growth Rate (2017-2019)
Figure Brazil Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Contraceptive Growth Rate (2017-2019)
Figure Argentina Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Contraceptive Growth Rate (2017-2019)
Figure Columbia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Contraceptive Growth Rate (2017-2019)
Figure Rest of South America Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Contraceptive Growth Rate (2017-2019)
Figure Middle East and Africa Contraceptive Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Contraceptive by Countries (2017-2019)
Figure Middle East and Africa Contraceptive Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Contraceptive Growth Rate (2017-2019)
Figure Saudi Arabia Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Contraceptive Growth Rate (2017-2019)
Figure United Arab Emirates Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Contraceptive Growth Rate (2017-2019)
Figure Egypt Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Contraceptive Growth Rate (2017-2019)
Figure Nigeria Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Contraceptive Growth Rate (2017-2019)
Figure South Africa Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Contraceptive Growth Rate (2017-2019)
Figure Turkey Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Contraceptive Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Contraceptive Revenue (Millions USD) and Growth Rate (2017-2019)
Table Teva Pharmaceutical Industries Contraceptive Financial Overview
Table The Female Health Company Contraceptive Financial Overview
Table Reckitt Benckiser Plc Contraceptive Financial Overview
Table Pfizer Inc. Contraceptive Financial Overview
Table Church & Dwight Contraceptive Financial Overview
Table Mayer Laboratories Contraceptive Financial Overview
Table Cooper Surgical Contraceptive Financial Overview
Table Actavis plc, Contraceptive Financial Overview
Table Merck & Co. Contraceptive Financial Overview
Figure Global Contraceptive Revenue (Millions USD) and Growth Rate (2019-2027)
Table Contraceptive Market Forecast by Regions (2019-2027)
Figure North America Contraceptive Market Forecast (2019-2027)
Figure United States Contraceptive Market Forecast (2019-2027)
Figure Canada Contraceptive Market Forecast (2019-2027)
Figure Mexico Contraceptive Market Forecast (2019-2027)
Figure Europe Contraceptive Market Forecast (2019-2027)
Figure Germany Contraceptive Market Forecast (2019-2027)
Figure France Contraceptive Market Forecast (2019-2027)
Figure UK Contraceptive Market Forecast (2019-2027)
Figure Russia Contraceptive Market Forecast (2019-2027)
Figure Italy Contraceptive Market Forecast (2019-2027)
Figure Rest of Europe Contraceptive Market Forecast (2019-2027)
Figure Asia-Pacific Contraceptive Market Forecast (2019-2027)
Figure China Contraceptive Market Forecast (2019-2027)
Figure Japan Contraceptive Market Forecast (2019-2027)
Figure Korea Contraceptive Market Forecast (2019-2027)
Figure India Contraceptive Market Forecast (2019-2027)
Figure Southeast Asia Contraceptive Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Contraceptive Market Forecast (2019-2027)
Figure South America Contraceptive Market Forecast (2019-2027)
Figure Brazil Contraceptive Market Forecast (2019-2027)
Figure Argentina Contraceptive Market Forecast (2019-2027)
Figure Columbia Contraceptive Market Forecast (2019-2027)
Figure Rest of South America Contraceptive Market Forecast (2019-2027)
Figure Middle East and Africa Contraceptive Market Forecast (2019-2027)
Figure Saudi Arabia Contraceptive Market Forecast (2019-2027)
Figure United Arab Emirates Contraceptive Market Forecast (2019-2027)
Figure Egypt Contraceptive Market Forecast (2019-2027)
Figure Nigeria Contraceptive Market Forecast (2019-2027)
Figure South Africa Contraceptive Market Forecast (2019-2027)
Figure Turkey Contraceptive Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Contraceptive Market Forecast (2019-2027)
Figure Global Contraceptive Forecast by Drug Type (2019-2027)
Figure Global Contraceptive Market Share Forecast by Drug Type (2019-2027)
Figure Global Contraceptive Forecast by Drug Type (2019-2027)
Figure Global Contraceptive Forecast by Device (2019-2027)
Figure Global Contraceptive Market Share Forecast by Device (2019-2027)
Figure Global Contraceptive Forecast by Device (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|